The University of Florida College of Pharmacy’s PGY2 Clinical Pharmacogenomics Residency is a one-year program within the UF Health Precision Medicine Program and the College of Pharmacy for professionals who have completed an ASHP-accredited PGY1 pharmacy residency.
The purpose of the PGY2 Clinical Pharmacogenomics Residency at UF is to build on the Doctor of Pharmacy education and PGY1 pharmacy residency training to develop clinical pharmacists who have the knowledge and skills needed to implement pharmacogenomics into clinical practice.
The Pharmacogenomics Clinic is a collaboration between pharmacogenomics specialists and primary care physicians.
Patients are seen in a two-visit model out of internal medicine and family medicine outpatient clinics. Clinic operates two half-days per week.
Education opportunities include a UF College of Pharmacy teaching certificate; a UF College of Pharmacy leadership development series; and access to Graduate Program in Precision Medicine materials.
Pharmacogenomics specialists, including the resident, are notified when pharmacogenetic results are returned for UF Health patients. Patient-centered recommendations are then provided to the ordering clinician for consideration when making pharmacotherapy decisions.
UF is one of five sites involved in the IGNITE-II network. The pharmacogenomics resident is involved with the pragmatic clinical trials and, in turn, gains exposure to a large, multi-site research effort.
Past Graduates in Their Current Roles
Available Learning Experiences
- Oncology (somatic and germline)
- And More!
How to Apply
- UF utilizes the Pharmacy Online Residency Centralized Application Service (PhORCAS). All candidates must also register with the ASHP Resident Matching Program.
- Your application must include the following materials, which must be uploaded to PhORCAS:
- Official transcripts from your college of pharmacy
- Curriculum vitae
- One-page letter of intent
- PhORCAS standardized reference form submitted by three references of your choosing
- Participation in Professional Placement Services (PPS) at ASHP Midyear Clinical Meeting is not required, but it is highly encouraged.
Applications are due by January 11, 2022
Pharmacotherapy & Translational Research
Kristin Wiisanen Pharm.D., FAPhA, FCCP
Clinical Professor; Associate Director Of The UF Health Precision Medicine Program; Director Of The Graduate Program In Precision Medicine; Director Of The Office Of Continuing Pharmacy Education